Cell Genesys, Japan Tobacco deal

By WIR Staff | Dec 21, 1998 | 8:00 AM GMT

The partners will develop CEGE's GVAX cancer vaccine worldwide to treat prostate cancer and a second indication to

Read the full 186 word article

How to gain access

Continue reading with a
two-week free trial.